ROMANELLI, ROBERTO GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 9.633
EU - Europa 5.612
AS - Asia 3.555
SA - Sud America 371
AF - Africa 87
OC - Oceania 80
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.341
Nazione #
US - Stati Uniti d'America 9.532
RU - Federazione Russa 2.146
SG - Singapore 1.051
PL - Polonia 811
CN - Cina 748
HK - Hong Kong 670
SE - Svezia 577
IE - Irlanda 539
IT - Italia 393
VN - Vietnam 378
BR - Brasile 305
KR - Corea 279
DE - Germania 256
UA - Ucraina 230
FI - Finlandia 193
FR - Francia 161
GB - Regno Unito 136
IN - India 106
AU - Australia 78
CH - Svizzera 71
TR - Turchia 64
JP - Giappone 56
CA - Canada 50
JO - Giordania 43
BD - Bangladesh 30
AR - Argentina 27
CI - Costa d'Avorio 27
MX - Messico 27
NL - Olanda 26
IQ - Iraq 23
PK - Pakistan 23
BE - Belgio 20
ID - Indonesia 18
NG - Nigeria 16
UZ - Uzbekistan 15
VE - Venezuela 12
ES - Italia 11
ZA - Sudafrica 11
MA - Marocco 10
CO - Colombia 8
BG - Bulgaria 7
AL - Albania 6
HN - Honduras 6
MY - Malesia 6
AZ - Azerbaigian 5
CL - Cile 5
EC - Ecuador 5
EG - Egitto 5
JM - Giamaica 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
DZ - Algeria 4
KE - Kenya 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
PT - Portogallo 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
EU - Europa 3
KG - Kirghizistan 3
KZ - Kazakistan 3
OM - Oman 3
PH - Filippine 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KH - Cambogia 2
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PW - Palau 1
RO - Romania 1
Totale 19.338
Città #
Santa Clara 2.006
Fairfield 859
Ashburn 835
Warsaw 806
Singapore 717
Chandler 592
Hong Kong 549
Dublin 538
Woodbridge 431
Seattle 375
Cambridge 374
Jacksonville 363
Houston 307
Wilmington 306
San Jose 280
Seoul 272
Beijing 236
Ann Arbor 164
The Dalles 161
Buffalo 149
Princeton 133
Ho Chi Minh City 122
Lawrence 113
Boston 112
Los Angeles 104
Altamura 100
Dallas 100
Lauterbourg 99
Boardman 97
Hanoi 84
Melbourne 77
Bern 70
Hefei 70
Mumbai 66
Florence 65
Munich 61
San Diego 55
Tokyo 55
Moscow 53
Medford 50
New York 48
Izmir 45
Shanghai 43
Paris 41
Helsinki 35
Kent 31
São Paulo 31
Turku 30
Redondo Beach 29
Dearborn 28
Milan 28
Abidjan 27
Norwalk 26
Bremen 23
Orem 23
Da Nang 22
London 22
Council Bluffs 19
Brooklyn 18
Chicago 18
Toronto 18
Montreal 17
Abuja 16
Brussels 14
Frankfurt Am Main 14
Frankfurt am Main 14
Tashkent 14
Chennai 13
Hillsboro 13
Andover 12
Auburn Hills 12
Falls Church 12
Guangzhou 12
Haiphong 11
Jakarta 11
Manchester 11
Washington 11
Baghdad 10
Dong Ket 10
Nanjing 10
Phoenix 9
San Francisco 9
Amman 8
Atlanta 8
Denver 8
Philadelphia 8
Redmond 8
Rome 8
Yubileyny 8
Amsterdam 7
Biên Hòa 7
Clifton 7
Hải Dương 7
Salerno 7
Stockholm 7
Verona 7
Antwerp 6
Belo Horizonte 6
Buenos Aires 6
Curitiba 6
Totale 12.995
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 365
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 338
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 311
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 311
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. 289
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 271
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 242
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 225
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 219
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 215
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 214
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 212
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 210
DRESS syndrome in a patient with chronic hepatic encephalopathy. 205
Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. 201
ADMA correlates with portal pressure in patients with compensated cirrhosis. 200
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis. 196
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 194
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 193
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 189
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 185
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 184
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association. 184
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 183
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 181
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 180
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 177
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 177
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 176
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 174
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 174
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 174
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 173
Screening of distress among hospitalized patients in a department of internal medicine. 172
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 170
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation from Italy 170
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 170
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 168
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 166
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 165
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 165
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 164
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 163
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 163
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 162
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 161
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. 159
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 158
QT adaptation during exercise in cirrhosis 155
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 154
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 154
Torasemide in the treatment of patients with cirrhosis and ascites. 151
Pathogenesis and treatment of ascites in hepatic cirrhosis. 151
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 151
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes 151
The src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling 149
Progression of fibrosis in chronic liver diseases: time to tally the score. 149
Hepato-systemic gradient of carbon monoxide in cirrhosis. 149
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 147
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 147
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 144
The cellular and molecular basis of liver fibrogenesis. 141
Organization of the lymphoid tissue in livers with chronic active hepatitis. 141
Uveitis in autoimmune hepatitis: a case report. 139
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 139
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 139
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 138
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 138
CXCR3-binding chemokines as survival factors in human hepatic stellate cells. 138
Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells. 137
IGF-I IS A SURVIVAL FACTOR FOR HUMAN HEPATIC STELLATE CELLS (HSC): INVOLVEMENT OF PI 3-K AND C-AKT 137
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 134
Progression of fibrosis in chronic liver diseases: time to tally the score 134
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. 133
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 132
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 132
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 132
L'alcol ed il metabolismo glicidico 131
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 130
Epatite da virus C e terapia interferonica 130
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. 129
Pathogenesis and treatment of ascites in hepatic cirrhosis. 129
EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION. 129
Il Fegato: Fisiopatologia, Clinica, Terapia 128
Alcol e metabolismo proteico 128
Renal impairement in chronic liver diseases with and without cholestasis 127
Update on ascites and hepatorenal syndrome 127
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 127
Effects of recombinant human gamma-interferon on advanced hepatocellular carcinoma 126
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats 124
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis 124
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 122
EFFECTS OF RECOMBINANT HUMAN GAMMA-INTERFERON ON ADVANCED HEPATOCELLULAR CARCINOMA 122
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 120
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 119
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 118
Hepatorenal syndrome and its treatment today. 118
Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. 116
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 115
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 113
Totale 16.586
Categoria #
all - tutte 52.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 0 92
2021/2022860 24 91 42 39 30 27 29 49 46 25 190 268
2022/20232.374 223 355 109 182 208 422 324 142 247 18 60 84
2023/2024731 22 97 142 48 49 103 26 161 9 19 30 25
2024/20255.666 161 602 381 902 1.841 614 89 323 290 115 180 168
2025/20264.547 679 768 356 246 568 185 598 220 478 312 107 30
Totale 19.377